Source Natural Foods P/B Ratio
Source Natural Foods P/B ratio. Source Natural Foods (SOURCENTRL) P/B ratio is 9.13 (High), book value per share ₹43.33 vs Healthcare average P/B of 0.01 — Very High - Significant premium, high growth expectations or speculative. Analyse SOURCENTRL institutional holdings to track promoter, FII and institutional holdings.
Current Valuation Metrics
Book Value Breakdown (2026)
Valuation Signal
Sector Context
SOURCENTRL P/B Ratio — Valuation Insights & Book Value Analysis
Source Natural Foods price-to-book ratio interpretation, valuation status and historical context — current P/B 9.13 (High). For live price, earnings yield and the full fundamental profile, see Source Natural Foods share price today.
- Stock appears overvalued with PB of 9.13, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Current PB is 126.2% above historical average
- Trading at premium to sector average PB of 0.01
Source Natural Foods P/B Ratio Historical Trend
SOURCENTRL annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. View SOURCENTRL 52-week high low for the annual high/low range and current price position.
SOURCENTRL Historical P/B Ratio — Book Value Per Share & Year-End Price
Source Natural Foods annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2026 | 2.65 | ₹43.33 | ₹115.00 | ₹26 | Moderate |
| 2025 | 3.68 | ₹36.67 | ₹134.95 | ₹22 | High |
| 2024 | 5.79 | ₹33.33 | ₹192.90 | ₹20 | High |
| 2023 | 3.4 | ₹30.0 | ₹102.09 | ₹18 | High |
| 2022 | 4.66 | ₹26.67 | ₹124.15 | ₹16 | High |
SOURCENTRL vs Healthcare Peers — P/B Ratio Comparison
Source Natural Foods P/B 9.13 vs Healthcare average 0.01, median 0.61 — range -6.55–1.07.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Parmax Pharma | PARMAX | -6.55 | ₹46 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -1.2 | ₹35 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.8 | ₹147 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.19 | ₹50 | Low |
| Triochem Products | TRIPR | 0.04 | ₹0 | Low |